{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:35:32Z","timestamp":1790674532811,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220684","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:16:09Z","timestamp":1567534569000},"page":"e0220684","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA)"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-1397","authenticated-orcid":true,"given":"Alan","family":"Hibbitts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Luc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Serrano-Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Matteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-844X","authenticated-orcid":true,"given":"Jos\u00e9 A.","family":"A\u00ednsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"2","key":"pone.0220684.ref001","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of Antibiotic Resistance","volume":"4","author":"JM Munita","year":"2016","journal-title":"Microbiology Spectrum"},{"issue":"1","key":"pone.0220684.ref002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"A Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pone.0220684.ref003","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41467-019-08853-3","article-title":"Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage","volume":"10","author":"RS Hendriksen","year":"2019","journal-title":"Nature Communications"},{"key":"pone.0220684.ref004","article-title":"Staphylococcus aureus infections","volume":"339","author":"FD Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"pone.0220684.ref005","article-title":"The economic burden of methicillin-resistant Staphylococcus aureus in community-onset pneumonia inpatients","author":"H Uematsu","year":"2016","journal-title":"Am J Infect Control"},{"issue":"1","key":"pone.0220684.ref006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2334-14-177","article-title":"Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus(VRE): a systematic review","volume":"14","author":"ES Shenoy","year":"2014","journal-title":"BMC Infectious Diseases"},{"key":"pone.0220684.ref007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2012.02.001","article-title":"National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010","volume":"40","author":"WR Jarvis","year":"2012","journal-title":"Am J Infect Control"},{"issue":"1","key":"pone.0220684.ref008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2334-11-138","article-title":"MRSA prevalence in european healthcare settings: a review","volume":"11","author":"M Dulon","year":"2011","journal-title":"BMC Infectious Diseases"},{"issue":"suppl","key":"pone.0220684.ref009","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1093\/clinids\/3.Supplement_2.S210","article-title":"The antibacterial action of vancomycin","volume":"3","author":"C Watanakunakorn","year":"1981","journal-title":"Reviews of infectious diseases"},{"issue":"Suppl D","key":"pone.0220684.ref010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/14.suppl_D.7","article-title":"Mode of action and in-vitro activity of vancomycin","volume":"14","author":"C Watanakunakorn","year":"1984","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"9888","key":"pone.0220684.ref011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(13)61219-2","article-title":"First case of infection with vancomycin-resistant Staphylococcus aureus in Europe","volume":"382","author":"J Melo-Cristino","year":"2013","journal-title":"The Lancet"},{"issue":"14","key":"pone.0220684.ref012","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vnAa Resistance Gene","volume":"348","author":"S Chang","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0220684.ref013","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13104-016-2252-7","article-title":"The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis","volume":"9","author":"S Tongsai","year":"2016","journal-title":"BMC research notes"},{"issue":"Supplement 1","key":"pone.0220684.ref014","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/491713","article-title":"Adaptation of Methicillin-Resistant Staphylococcus aureus in the Face of Vancomycin Therapy","volume":"42","author":"G Sakoulas","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"pone.0220684.ref015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14740330903413514","article-title":"Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections","volume":"9","author":"ED Hermsen","year":"2010","journal-title":"Expert Opinion on Drug Safety"},{"issue":"2","key":"pone.0220684.ref016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","article-title":"Alternatives to antibiotics\u2014a pipeline portfolio review","volume":"16","author":"L Czaplewski","year":"2016","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0220684.ref017","doi-asserted-by":"crossref","first-page":"41242","DOI":"10.1038\/srep41242","article-title":"Antimicrobial Nanoplexes meet Model Bacterial Membranes: the key role of Cardiolipin","volume":"7","author":"A Mar\u00edn-Men\u00e9ndez","year":"2017","journal-title":"Scientific reports"},{"key":"pone.0220684.ref018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.colsurfb.2016.03.031","article-title":"Interaction between a cationic bolaamphiphile and DNA: The route towards nanovectors for oligonucleotide antimicrobials","volume":"143","author":"M Mamusa","year":"2016","journal-title":"Colloids and surfaces B, Biointerfaces"},{"issue":"9","key":"pone.0220684.ref019","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI11459","article-title":"Therapeutic applications of transcription factor decoy oligonucleotides","volume":"106","author":"MJ Mann","year":"2000","journal-title":"The Journal of clinical investigation"},{"issue":"22","key":"pone.0220684.ref020","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1128\/JB.00645-07","article-title":"New Insights into the WalK\/WalR (YycG\/YycF) Essential Signal Transduction Pathway Reveal a Major Role in Controlling Cell Wall Metabolism and Biofilm Formation in Staphylococcus aureus","volume":"189","author":"S Dubrac","year":"2007","journal-title":"Journal of Bacteriology"},{"issue":"11","key":"pone.0220684.ref021","doi-asserted-by":"crossref","first-page":"e1002359","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"BP Howden","year":"2011","journal-title":"PLoS pathogens"},{"key":"pone.0220684.ref022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cej.2017.12.110","article-title":"New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules","volume":"340","author":"L De Matteis","year":"2018","journal-title":"Chemical Engineering Journal"},{"issue":"9","key":"pone.0220684.ref023","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1586\/eri.12.90","article-title":"WhiB7, a transcriptional activator that coordinates physiology with intrinsic drug resistance in Mycobacterium tuberculosis","volume":"10","author":"J Burian","year":"2012","journal-title":"Expert Review of Anti-infective Therapy"},{"issue":"11","key":"pone.0220684.ref024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01347-17","article-title":"Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance","volume":"61","author":"K Hurst-Hess","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pone.0220684.ref025","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/la104221q","article-title":"How to prepare and stabilize very small nanoemulsions","volume":"27","author":"T Delmas","year":"2011","journal-title":"Langmuir"},{"issue":"8","key":"pone.0220684.ref026","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"JC Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pone.0220684.ref027","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/AAC.00474-11","article-title":"Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen","volume":"55","author":"S Ram\u00f3n-Garc\u00eda","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"pone.0220684.ref028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12915-017-0423-1","article-title":"Antibiotic resistance: it\u2019s bad, but why isn\u2019t it worse?","volume":"15","author":"N Waglechner","year":"2017","journal-title":"BMC Biology"},{"issue":"7","key":"pone.0220684.ref029","doi-asserted-by":"crossref","first-page":"e102135","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline","volume":"9","author":"K Andries","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"pone.0220684.ref030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/cix992","article-title":"Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention","volume":"66","author":"TVA Nguyen","year":"2017","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"pone.0220684.ref031","first-page":"e00239","article-title":"Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis","volume":"61","author":"J Xu","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"pone.0220684.ref032","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5694\/j.1326-5377.2001.tb143681.x","article-title":"Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin","volume":"175","author":"PB Ward","year":"2001","journal-title":"The Medical journal of Australia"},{"issue":"5","key":"pone.0220684.ref033","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2174\/1567201812666150817123528","article-title":"Efficient Transfection of Phosphorothioate Oligodeoxyribonucleotides by lipofectamine2000 into Different Bacteria","volume":"13","author":"Z Chen","year":"2016","journal-title":"Current drug delivery"},{"issue":"17","key":"pone.0220684.ref034","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1039\/C4CS00487F","article-title":"Nanoparticle colloidal stability in cell culture media and impact on cellular interactions","volume":"44","author":"TL Moore","year":"2015","journal-title":"Chemical Society Reviews"},{"issue":"9","key":"pone.0220684.ref035","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1021\/mp500329z","article-title":"FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles","volume":"11","author":"J Gravier","year":"2014","journal-title":"Molecular pharmaceutics"},{"issue":"2","key":"pone.0220684.ref036","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcis.2011.04.080","article-title":"Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity","volume":"360","author":"T Delmas","year":"2011","journal-title":"Journal of colloid and interface science"},{"issue":"Supplement C","key":"pone.0220684.ref037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biomaterials.2017.05.001","article-title":"Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies","volume":"136","author":"T Courant","year":"2017","journal-title":"Biomaterials"},{"issue":"109","key":"pone.0220684.ref038","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cis.2003.10.023","article-title":"Formation and stability of nano-emulsions","volume":"108","author":"T Tadros","year":"2004","journal-title":"Advances in Colloid and Interface Science"},{"issue":"2","key":"pone.0220684.ref039","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2004.02.029","article-title":"Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes","volume":"97","author":"K Tabatt","year":"2004","journal-title":"Journal of Controlled Release"},{"key":"pone.0220684.ref040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2017.11.004","article-title":"Transcription factors: Time to deliver","volume":"269","author":"AV Ulasov","year":"2018","journal-title":"Journal of Controlled Release"},{"key":"pone.0220684.ref041","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","article-title":"Transcription factor decoy technology: A therapeutic update","volume":"144","author":"M Hecker","year":"2017","journal-title":"Biochemical Pharmacology"},{"key":"pone.0220684.ref042","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2018.11.017","article-title":"Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides","volume":"134","author":"A Gonz\u00e1lez-Paredes","year":"2019","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"2","key":"pone.0220684.ref043","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/ma11020321","article-title":"Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus","volume":"11","author":"A Hibbitts","year":"2018","journal-title":"Materials"},{"issue":"33","key":"pone.0220684.ref044","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","author":"SEA Gratton","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"23","key":"pone.0220684.ref045","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1039\/C8SC01828F","article-title":"The morphology and surface charge-dependent cellular uptake efficiency of upconversion nanostructures revealed by single-particle optical microscopy","volume":"9","author":"D Zhang","year":"2018","journal-title":"Chemical Science"},{"issue":"5","key":"pone.0220684.ref046","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/pharmaceutics11050236","article-title":"Bacteria-Targeted Clindamycin Loaded Polymeric Nanoparticles: Effect of Surface Charge on Nanoparticle Adhesion to MRSA, Antibacterial Activity, and Wound Healing","volume":"11","author":"N Hasan","year":"2019","journal-title":"Pharmaceutics"},{"key":"pone.0220684.ref047","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.colsurfb.2012.11.012","article-title":"Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers","volume":"103","author":"Y Liu","year":"2013","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"9","key":"pone.0220684.ref048","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion","volume":"29","author":"ZR Huang","year":"2008","journal-title":"Acta Pharmacol Sin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:20:35Z","timestamp":1588972835000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220684"}},"subtitle":[],"editor":[{"given":"Prabagaran","family":"Narayanasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220684","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]}}}